SHAREHOLDER ALERT: WeissLaw LLP Reminds DWSN, PAE, ADMS, and ACBI Shareholders About Its Ongoing InvestigationsPRNewsWire • 11/09/21
SHAREHOLDER ALERT: WeissLaw LLP Reminds OMP, ADMS, ACBI and ECHO Shareholders About Its Ongoing InvestigationsPRNewsWire • 11/03/21
ADAMAS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMSPRNewsWire • 11/02/21
Will Adamas Pharmaceuticals (ADMS) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/28/21
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the FirmPRNewsWire • 10/28/21
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing InvestigationsPRNewsWire • 10/27/21
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Adamas Pharmaceuticals, Inc. - ADMSPRNewsWire • 10/16/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Adamas Pharmaceuticals, Inc. with Supernus Pharmaceuticals, Inc.Newsfile Corp • 10/11/21
Shareholder Alert: Ademi LLP investigates whether Adamas Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with SupernusPRNewsWire • 10/11/21
Adamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ADMSBusiness Wire • 10/11/21
Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health AwardsBusiness Wire • 10/01/21
Adamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society's (MDS) CongressBusiness Wire • 09/16/21
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
Adamas Pharmaceuticals (ADMS) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/09/21
Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021Business Wire • 08/02/21
Adamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/29/21